Neurology News and Research

Latest Neurology News and Research

Researchers show inhibiting brain's filter can boost performance for tasks

The brain's prefrontal cortex is thought to be the seat of cognitive control, working as a kind of filter that keeps irrelevant thoughts, perceptions and memories from interfering with a task at hand.

15 Mar 2013

Researchers find no overall recovery benefit to patients treated with clot-removal devices

When someone has a stroke, time equals brain. The longer a stroke is left untreated, the more brain tissue is lost. Since the only proven treatment - a clot-busting drug - works in less than half of patients, stroke physicians had high hopes for a mechanical device that could travel through the blocked blood vessel to retrieve or break up the clot, restoring blood flow to the brain.

15 Mar 2013

Prescribing attention-boosting drugs for healthy kids is misguided

The American Academy of Neurology (AAN), the world's largest professional association of neurologists, is releasing a position paper on how the practice of prescribing drugs to boost cognitive function, or memory and thinking abilities, in healthy children and teens is misguided.

14 Mar 2013

Phase 1b study of olesoxime initiated in multiple sclerosis (MS) patients

...

14 Mar 2013

VCP gene mutations cause neurological conditions including IBMPFD and ALS

New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of neurological conditions including a form of dementia called Inclusion Body Myopathy, Paget's Disease of the Bone and Frontotemporal Dementia (IBMPFD), and the motor neuron disease Amyotrophic Lateral Sclerosis (ALS).

14 Mar 2013

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.

14 Mar 2013

UH Case Medical Center joins elite group of providers focused on complex stroke care

University Hospitals (UH) Case Medical Center has become the first hospital in Northeast Ohio and 19th in the nation to achieve The Joint Commission's standards for Comprehensive Stroke Center Certification, joining an elite group of providers focused on complex stroke care.

14 Mar 2013

Iron imbalance caused by prion proteins leads to cell death in CJD, researchers find

An iron imbalance caused by prion proteins collecting in the brain is a likely cause of cell death in Creutzfeldt-Jakob disease (CJD), researchers at Case Western Reserve University School of Medicine have found.

14 Mar 2013

New research shows dystextia may become vital tool for diagnosing stroke

Difficulty or inability to write a coherent text message, even in patients who have no problem speaking, may become a "vital" tool in diagnosing a type of crippling stroke, according to new research at Henry Ford Hospital.

14 Mar 2013

Brain imaging can detect tiny lesions that may provide target for treating people with mTBI: Study

Brain imaging soon after mild traumatic brain injury or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

13 Mar 2013

MGH investigators identify new disease that causes widespread chronic pain in children

Massachusetts General Hospital (MGH) investigators have described what may be a newly identified disease that appears to explain some cases of widespread chronic pain and other symptoms in children and young adults.

13 Mar 2013

Telemedicine house calls may be comparable to in-person care for people with Parkinson’s

A small study of 20 people with Parkinson’s disease suggests that “virtual house calls” using Web-based video conferencing provide clinical benefits comparable to in-person physician office visits, while saving patients and their caregivers time and travel.

12 Mar 2013

Peer support groups help combat epilepsy-related stigma

Peer support groups show promise for combating the debilitating stigma that surrounds epilepsy in much of the developing world, according to a new study led by a Michigan State University medical student.

12 Mar 2013

Sleep problems may be indicator of early Alzheimer's disease

Sleep is disrupted in people who likely have early Alzheimer's disease but do not yet have the memory loss or other cognitive problems characteristic of full-blown disease, researchers at Washington University School of Medicine in St. Louis report March 11 in JAMA Neurology.

12 Mar 2013

Results from Orion Pharma’s ORM-12741 phase IIa study on AD

A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.

12 Mar 2013

NIH-sponsored comparative trial evaluates benefits of combination therapy and monotherapy in MS

People with multiple sclerosis (MS) who were treated with combination therapy did not see significant clinical benefit over those treated with single drug therapy, but combination therapy did reduce the development of new lesions, according to an international research team led by The Mount Sinai Medical Center.

12 Mar 2013

Combination of INF and glatiramer acetate does not reduce MS progression

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together.

12 Mar 2013

Buphenyl may protect memory and prevent progression of Alzheimer's

Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease.

12 Mar 2013

Virtual house calls provide clinical benefits for patients with Parkinson's

A small study of 20 people with Parkinson's disease suggests that "virtual house calls" using Web-based video conferencing provide clinical benefits comparable to in-person physician office visits, while saving patients and their caregivers time and travel.

12 Mar 2013

Sanford-Burnham, Mayo Clinic partner to expand and speed development of new drugs

To expand and speed the development of new drugs for its patients, Mayo Clinic has entered a formal collaboration with Sanford-Burnham Medical Research Institute. Under the agreement, Mayo's discoveries of potential drug targets will be the basis for the development of new drug screening platforms. This will allow future work that focuses on high-throughput screening and medicinal chemistry at Sanford-Burnham facilities.

12 Mar 2013

Neurology News and Research

Latest Neurology News and Research

Researchers show inhibiting brain's filter can boost performance for tasks

Researchers find no overall recovery benefit to patients treated with clot-removal devices

Prescribing attention-boosting drugs for healthy kids is misguided

Phase 1b study of olesoxime initiated in multiple sclerosis (MS) patients

VCP gene mutations cause neurological conditions including IBMPFD and ALS

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

UH Case Medical Center joins elite group of providers focused on complex stroke care

Iron imbalance caused by prion proteins leads to cell death in CJD, researchers find

New research shows dystextia may become vital tool for diagnosing stroke

Brain imaging can detect tiny lesions that may provide target for treating people with mTBI: Study

MGH investigators identify new disease that causes widespread chronic pain in children

Telemedicine house calls may be comparable to in-person care for people with Parkinson’s

Peer support groups help combat epilepsy-related stigma

Sleep problems may be indicator of early Alzheimer's disease

Results from Orion Pharma’s ORM-12741 phase IIa study on AD

NIH-sponsored comparative trial evaluates benefits of combination therapy and monotherapy in MS

Combination of INF and glatiramer acetate does not reduce MS progression

Buphenyl may protect memory and prevent progression of Alzheimer's

Virtual house calls provide clinical benefits for patients with Parkinson's

Sanford-Burnham, Mayo Clinic partner to expand and speed development of new drugs

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Neurology News and Research

Latest Neurology News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in